CVE-2023-39537: Improper input validation in BIOS TCG2
First published: Tue Nov 14 2023(Updated: )
AMI AptioV contains a vulnerability in BIOS where an Attacker may use an improper input validation via the local network. A successful exploit of this vulnerability may lead to a loss of confidentiality, integrity and availability.
Credit: biossecurity@ami.com
| Affected Software | Affected Version | How to fix |
|---|---|---|
| Ami Aptio V |
Never miss a vulnerability like this again
Sign up to SecAlerts for real-time vulnerability data matched to your software, aggregated from hundreds of sources.
Reference Links
Frequently Asked Questions
What is CVE-2023-39537?
CVE-2023-39537 is a vulnerability in AMI AptioV BIOS that allows an attacker to exploit improper input validation via the local network, potentially leading to a loss of confidentiality, integrity, and availability.
What is the severity of CVE-2023-39537?
CVE-2023-39537 has a severity rating of 7.5 (High).
How does CVE-2023-39537 affect AMI AptioV?
CVE-2023-39537 affects AMI AptioV BIOS software.
How can an attacker exploit CVE-2023-39537?
An attacker can exploit CVE-2023-39537 by using improper input validation through the local network.
How can I fix CVE-2023-39537?
To fix CVE-2023-39537, it is recommended to follow the instructions provided in the AMI-SA-2023008 security advisory.
- collector/nvd-api
- agent/title
- agent/weakness
- agent/severity
- agent/references
- agent/author
- agent/type
- agent/event
- agent/description
- agent/last-modified-date
- agent/softwarecombine
- agent/first-publish-date
- agent/tags
- collector/mitre-cve
- source/MITRE
- vendor/ami
- canonical/ami aptio v